In another recent study, it was shown that NSCLC cells survive EGFR and MEK dual inhibition by entering a senescence-like state, which is accompanied by up-regulation of the YAP/TEAD pathway. This evidence concerns the gene EGFR and non-small cell lung carcinoma.